Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 58

1.
2.

From state-of-the-art cell therapy to endogenous cardiac repair.

Mohl W, Henry TD, Milasinovic D, Nguemo F, Hescheler J, Perin EC.

EuroIntervention. 2017 Aug 25;13(6):760-772. doi: 10.4244/EIJ-D-17-00467. Review.

3.

First in man prolonged pressure-controlled intermittent coronary sinus occlusion to treat refractory left ventricular dysfunction and ischemia with patent epicardial coronary arteries.

Pappalardo F, Ancona MB, Giannini F, Regazzoli D, Mangieri A, Montorfano M, De Bonis M, Alfieri O, Zangrillo A, Scandroglio AM, Colombo A, Latib A.

Int J Cardiol. 2017 Aug 15;241:138-141. doi: 10.1016/j.ijcard.2017.05.030. Epub 2017 May 9.

PMID:
28501350
4.

High-risk left main percutaneous coronary intervention supported by pressure-controlled intermittent coronary sinus occlusion.

Azzalini L, Montorfano M, Latib A, Colombo A.

EuroIntervention. 2016 Dec 10;12(11):e1437. doi: 10.4244/EIJ-D-16-00096. No abstract available.

5.

Physiological Contribution in Spontaneous Oscillations: An Approximate Quality-Assurance Index for Resting-State fMRI Signals.

Hsu AL, Chou KH, Chao YP, Fan HY, Wu CW, Chen JH.

PLoS One. 2016 Feb 12;11(2):e0148393. doi: 10.1371/journal.pone.0148393. eCollection 2016.

6.

Contemporary perspective on endogenous myocardial regeneration.

Milasinovic D, Mohl W.

World J Stem Cells. 2015 Jun 26;7(5):793-805. doi: 10.4252/wjsc.v7.i5.793. Review.

7.

Pressure-controlled intermittent coronary sinus occlusion (PICSO) in acute ST-segment elevation myocardial infarction: results of the Prepare RAMSES safety and feasibility study.

van de Hoef TP, Nijveldt R, van der Ent M, Neunteufl T, Meuwissen M, Khattab A, Berger R, Kuijt WJ, Wykrzykowska J, Tijssen JG, van Rossum AC, Stone GW, Piek JJ.

EuroIntervention. 2015 May;11(1):37-44. doi: 10.4244/EIJY15M03_10.

8.

PICSO: from myocardial salvage to tissue regeneration.

Mohl W, Gangl C, Jusić A, Aschacher T, De Jonge M, Rattay F.

Cardiovasc Revasc Med. 2015 Jan-Feb;16(1):36-46. doi: 10.1016/j.carrev.2014.12.004. Epub 2014 Dec 23. Review.

9.

Prediction of anticancer activity of diterpenes isolated from the paraiban flora through a PLS model and molecular surfaces.

Scotti L, Scotti MT, Ishiki H, Junior FJ, dos SP, Tavares JF, da Silva MS.

Nat Prod Commun. 2014 May;9(5):609-12.

PMID:
25026699
10.

Effect of pressure-controlled intermittent coronary sinus occlusion (PICSO) on myocardial ischaemia and reperfusion in a closed-chest porcine model.

Khattab AA, Stieger S, Kamat PJ, Vandenberghe S, Bongoni A, Stone GW, Seiler C, Meier B, Hess OM, Rieben R.

EuroIntervention. 2013 Jul;9(3):398-406. doi: 10.4244/EIJV9I3A63.

11.

Effects of coronary sinus occlusion on myocardial ischaemia in humans: role of coronary collateral function.

Stoller M, Traupe T, Khattab AA, de Marchi SF, Steck H, Seiler C.

Heart. 2013 Apr;99(8):548-55. doi: 10.1136/heartjnl-2012-303305. Epub 2013 Jan 23.

PMID:
23343686
12.

Intracoronary hemodynamic effects of pressure-controlled intermittent coronary sinus occlusion (PICSO): results from the First-In-Man Prepare PICSO Study.

Van de Hoef TP, Nolte F, Delewi R, Henriques JP, Spaan JA, Tijssen JG, Siebes M, Wykrzykowska JJ, Stone GW, Piek JJ.

J Interv Cardiol. 2012 Dec;25(6):549-56. doi: 10.1111/j.1540-8183.2012.00768.x. Epub 2012 Sep 20.

PMID:
22994798
13.

Myocardial protection via the coronary sinus.

Mohl W, Komamura K, Kasahara H, Heinze G, Glogar D, Hirayama A, Kodama K.

Circ J. 2008 Apr;72(4):526-33.

14.

Intermittent pressure elevation of the coronary venous system as a method to protect ischemic myocardium.

Mohl W, Kajgana I, Bergmeister H, Rattay F.

Interact Cardiovasc Thorac Surg. 2005 Feb;4(1):66-9. Epub 2004 Dec 17.

PMID:
17670358
15.

Beck and back: a paradigm change in coronary sinus interventions--pulsatile stretch on intact coronary venous endothelium.

Weigel G, Kajgana I, Bergmeister H, Riedl G, Glogar HD, Gyöngyösi M, Blasnig S, Heinze G, Mohl W.

J Thorac Cardiovasc Surg. 2007 Jun;133(6):1581-7.

16.

Influences of signal quality for determination of PICSO timing.

Mina S, Meindl M, Mohl W.

Wien Klin Wochenschr. 2007;119(11-12 Suppl 1):31-2. No abstract available.

PMID:
19618600
17.

Soluble plasma factors derived from ischemic, PICSO-treated, porcine hearts are not responsible for HO-1 and VEGF mRNA expression in endothelial cells.

Schuler M, Winter B, Eichmair E, Nigisch A, Mohl W, Weigel G.

Wien Klin Wochenschr. 2007;119(11-12 Suppl 1):30. No abstract available.

PMID:
19618599
18.

PICSO in progress: lactate, oxygen, eNOS, iNOS, MMP and TIMP in the PICSO treated myocardium--a preview.

Lechner J, Grünbichler H, Schrutka I, Waldthaler A, Franz C, Mohl W.

Wien Klin Wochenschr. 2007;119(11-12 Suppl 1):29. No abstract available.

PMID:
19618598
19.

Do long term effects after PICSO endorse the potential of cardiac regeneration after acute myocardial infarction?

Kasahara H, Komamura K, Glogar D, Kodama K, Hirayama A, Mohl W.

Wien Klin Wochenschr. 2007;119(11-12 Suppl 1):23-6. No abstract available.

PMID:
19618595
20.

Intermittent coronary sinus occlusion complicating coronary sinus cannulation during coronary artery bypass operation.

Dabbah S, Reisner SA, Adler Z, Milo S, Agmon Y.

J Am Soc Echocardiogr. 2005 Aug;18(8):883.

PMID:
16084342

Supplemental Content

Loading ...
Support Center